Prof. Jennifer Martin, Royal Brisbane and Women’s Hospital and The University of Queensland, Australia
- Thu Sep 26 11:00 AM - 12:30 PM Imperial CThe Role of Pharmacokinetics in Appropriate Dosing for Obese Patients with Cancer
Associate Professor Jennifer Martin is Head of the PA-Southside Clinical School and a physician at the Princess Alexandra Hospital. She has been involved in teaching, training and curriculum development for medical students and physicians for 20 years. Her current research portfolio includes a multi-disciplinary and multi-institution medicines research group in the Translational Research Institute. This links basic pharmacology, drug design and clinical trial development with patient specific factors such as body size (particularly obesity), pharmacogenetic factors and disease specific profiles (using genetics and imaging) to target and individualise drug dosing. Dosing in obesity has become a focus of her clinical interests as large numbers of patients requiring pharmacotherapy are currently overweight or obese. She has also skills and experience in health economics which has been used to guide pharmacology research and practice, and in particular choosing the right dose for the correct pharmacokinetic profile.